Writer

Writer is the American enterprise generative AI company founded in 2020 by May Habib and Waseem Alshikh as a pivot from Qordoba, developer of the Palmyra enterprise foundation models, with $200 million Series C in November 2024 at $1.9 billion valuation and 250+ Fortune 500 customers.
Writer

Writer

Writer is an American enterprise generative AI company headquartered in San Francisco, founded in 2020 by May Habib and Waseem Alshikh as a strategic pivot from Qordoba, the localization-software company the two had founded in 2015. Writer develops the Writer enterprise generative AI platform alongside the Palmyra family of in-house enterprise foundation models, positioned explicitly as an enterprise-trustworthy alternative to the API-based foundation-model offerings from frontier labs. The company is the principal full-stack enterprise GenAI vendor that has built its own foundation models rather than re-selling OpenAI or Anthropic API capacity, with the Palmyra-X4 and Palmyra-X5 models trained in-house and deployed inside customer environments to address the data-egress and audit-control concerns that anchor enterprise procurement decisions in regulated industries. As of April 2026, Writer reports a customer base of over 350 enterprise organizations including Accenture, Vanguard, L'Oréal, Lululemon, Marriott, PwC, Salesforce, Intuit, Spotify, and Mars, and has raised over $326 million in cumulative private capital with a $1.9 billion valuation as of the November 2024 Series C.

At a glance

  • Founded: 2020 in San Francisco by May Habib and Waseem Alshikh as a pivot from Qordoba (which the same founding pair had launched in 2015).
  • Status: Private. Series C in November 2024 at $1.9 billion post-money valuation.
  • Funding: Approximately $326 million in cumulative private capital. Series C of $200 million in November 2024 led by Premji Invest and Radical Ventures with ICONIQ Capital, Salesforce Ventures, B Capital, Adobe Ventures, Citi Ventures, Workday Ventures, and IBM Ventures participating. Series B of $100 million (September 2023) led by ICONIQ Capital. Series A of $21 million (October 2021) led by Insight Partners. Earlier seed and Qordoba-period financing.
  • CEO: May Habib, Co-Founder and Chief Executive Officer. Lebanese-American; Harvard graduate (Phi Beta Kappa) with previous experience at Lehman Brothers, the Boston Consulting Group, and Mubadala (the Abu Dhabi sovereign wealth fund) before founding Qordoba in 2015.
  • Other notable leadership: Waseem Alshikh, Co-Founder and Chief Technology Officer. Computer-science background; provides technology leadership for the Palmyra foundation-model line and the broader platform.
  • Open weights: Yes, partial. Selected smaller Palmyra variants released open-weights through Hugging Face. Production-deployment Palmyra-X4 and Palmyra-X5 are closed.
  • Flagship products: Palmyra enterprise foundation-model family — Palmyra-X4, Palmyra-X5, the domain-specialized Palmyra-Med (healthcare) and Palmyra-Fin (financial services), and the Palmyra-Vision multimodal variant. The Writer enterprise GenAI platform combining Palmyra with workflow tooling, Knowledge Graph, AI Studio for application development, and AskWriter for enterprise-employee conversational access.

Origins

Writer's lineage traces to Qordoba, the localization-software company May Habib and Waseem Alshikh founded in 2015 in San Francisco. Habib's pre-Qordoba career had included roles at Lehman Brothers, the Boston Consulting Group, and Mubadala, where she had observed firsthand the friction enterprise organizations experienced in producing localized content across multiple languages and regulatory contexts. Qordoba raised approximately $30 million across 2016 to 2019 as a content-localization platform, with customer relationships built across Fortune-500 marketing, communications, and product-localization functions.

The 2019 to 2020 strategic pivot from Qordoba to Writer reflected Habib's and Alshikh's observation that the same enterprise customer base that bought localization tooling needed broader content-quality and brand-consistency capability that early NLP and generative-AI techniques had begun to make tractable. The 2020 Writer rebrand was effectively a strategic relaunch with the existing customer base and engineering team, repositioned around content-quality assurance, brand-consistency enforcement, and AI-augmented enterprise content creation rather than language localization. The company's earliest enterprise customers included L'Oréal, Spotify, and adjacent brand-conscious enterprise organizations.

The 2021 to 2022 period built the enterprise-trust positioning. Writer added compliance, audit-trail, and data-residency capabilities that frontier-API alternatives could not match, and the company began developing in-house foundation-model capability rather than re-selling third-party APIs. The October 2021 Series A of $21 million led by Insight Partners provided growth-equity capital. The September 2023 Series B of $100 million led by ICONIQ Capital scaled the engineering organization and supported Palmyra foundation-model development.

The April 2024 release of Palmyra-X 32B and the subsequent Palmyra-X4 and Palmyra-X5 variants established Writer's foundation-model capability at competitive scale. The domain-specialized Palmyra-Med and Palmyra-Fin variants — released through 2024 to 2025 — extended the line into regulated-industry specialized variants. The November 2024 Series C of $200 million at $1.9 billion valuation was led by Premji Invest and Radical Ventures with substantial strategic-investor participation including Salesforce Ventures, Adobe Ventures, Citi Ventures, Workday Ventures, and IBM Ventures.

The 2024 to 2026 period has continued enterprise-customer expansion. Industry coverage has reported the customer base growing from approximately 250 Fortune 500 organizations at the time of the Series C to over 350 enterprise organizations through 2025, with named customers including Accenture, Vanguard, L'Oréal, Lululemon, Marriott, PwC, Salesforce, Intuit, Spotify, Mars, and Uber.

Mission and strategy

Writer's stated mission is to be the principal enterprise generative AI platform globally, with explicit emphasis on the enterprise-trust posture that distinguishes the company from API-based frontier alternatives. The strategy combines three threads. First, the in-house Palmyra foundation-model family, including domain-specialized Palmyra-Med and Palmyra-Fin variants for regulated-industry deployments. Second, the Writer enterprise platform that combines Palmyra with workflow integration, Knowledge Graph for enterprise-data grounding, AI Studio for customer-built application development, and AskWriter for conversational enterprise access. Third, the strategic-investor relationships (Salesforce Ventures, Adobe Ventures, IBM Ventures, Workday Ventures, Citi Ventures) that anchor enterprise distribution partnerships and reduce the customer-acquisition friction that horizontal API providers face in regulated enterprise sectors.

The competitive premise is that enterprise generative AI is structurally a different commercial problem from horizontal API access — that data residency, audit trails, regulated-industry compliance, brand-consistency enforcement, and integration with existing enterprise data and workflows matter more to enterprise buyers than raw model capability, and that a vertically integrated company that builds its own models, platform, and integration layer can capture this segment in ways that horizontal API providers cannot.

Models and products

  • Palmyra-X4 and Palmyra-X5. The principal Writer foundation models. Closed-weights production deployments. Trained in-house on enterprise-relevant content with attention to factual reliability, brand-style adherence, and integration with the Writer Knowledge Graph.
  • Palmyra-Med. Healthcare-specialized variant. Trained for clinical-content workflows with relevant safety and regulatory considerations.
  • Palmyra-Fin. Financial-services-specialized variant. Trained for regulated financial-content workflows.
  • Palmyra-Vision. Multimodal variant for image and document understanding.
  • Writer enterprise GenAI platform. Web-based platform integrating AI capabilities into enterprise content creation, analysis, brand-consistency enforcement, and adjacent enterprise-content workflows.
  • Writer Knowledge Graph. Enterprise knowledge-graph capability for AI-augmented enterprise data understanding.
  • AI Studio. Application-development environment for enterprise customers building custom AI applications on Writer infrastructure.
  • AskWriter. Enterprise AI assistant for employee-facing access.

Distribution channels include direct enterprise sales (the principal channel), Salesforce Ventures and adjacent strategic-partner ecosystem distribution, and selected open-weights releases of smaller Palmyra variants through Hugging Face for developer-community engagement.

Benchmarks and standing

Writer publishes Palmyra benchmark results positioning the in-house models competitively against contemporary frontier alternatives on text-generation, instruction-following, and selected enterprise-relevant evaluation tasks. The Palmyra-X 32B (April 2024) results positioned the model competitively with Llama 3 70B on reasoning benchmarks at substantially smaller parameter count, and the Palmyra-Med variant has been published with healthcare-specific evaluation results.

Industry coverage has consistently grouped Writer with Cohere, AI21 Labs, and Aleph Alpha as the principal enterprise-AI platform Insurgents that operate their own foundation models rather than re-selling frontier-API capacity. Writer's distinguishing positioning within that group is the deeper US Fortune-500 customer traction (with named-customer count exceeding peer enterprise-AI Insurgents) and the domain-specialized Palmyra-Med and Palmyra-Fin variants for regulated-industry deployment.

Leadership

As of April 2026, Writer's senior leadership includes:

  • May Habib, Co-Founder and Chief Executive Officer.
  • Waseem Alshikh, Co-Founder and Chief Technology Officer.
  • Senior research, engineering, and commercial leadership across the Palmyra foundation-model program, the platform engineering organization, and the enterprise commercial team.

The founding team has been stable across the Qordoba and Writer periods.

Funding and backers

  • Qordoba period (2015 to 2019): Approximately $30 million across multiple rounds.
  • Series A (October 2021): $21 million led by Insight Partners.
  • Series B (September 2023): $100 million led by ICONIQ Capital.
  • Series C (November 2024): $200 million led by Premji Invest and Radical Ventures with ICONIQ Capital, Salesforce Ventures, B Capital, Adobe Ventures, Citi Ventures, Workday Ventures, and IBM Ventures participating. $1.9 billion post-money valuation.
  • Cumulative capital approximately $326 million as of April 2026.

Industry position

Writer occupies a distinctive position among enterprise generative AI Insurgents, with the unusual combination of in-house foundation-model capability (most enterprise AI platforms re-sell frontier APIs), the Fortune-500 customer-relationship breadth, the domain-specialized Palmyra-Med and Palmyra-Fin variants for regulated industries, and the strategic-investor relationships across Salesforce, Adobe, IBM, Workday, and Citi. Industry coverage has consistently characterized Writer as one of the structurally consequential enterprise GenAI Insurgents of the post-2022 wave, with the November 2024 Series C and the broad strategic-investor cohort as principal validating data points.

The structural risks are two. First, frontier-API providers (OpenAI, Anthropic, Google DeepMind) have continued to improve their enterprise-deployment offerings (data residency, audit trails, customer-managed instances) and have closed some of the enterprise-trust gap that Writer's positioning depends on. Second, hyperscale-cloud-aligned enterprise AI competitors (Microsoft AI Copilot, Salesforce AI Research Agentforce, Databricks Mosaic AI) bring distribution scale that purpose-built Insurgents cannot match.

Competitive landscape

Outlook

  • Continued Fortune 500 customer expansion through 2026 to 2027.
  • Continued Palmyra release cadence and any Palmyra-X6 or successor announcement.
  • Additional domain-specialized Palmyra variants beyond Palmyra-Med and Palmyra-Fin.
  • Potential additional fundraising at higher valuations or strategic-partner cooperation.
  • The competitive dynamic with hyperscale-cloud-aligned enterprise AI competitors as those offerings mature.

Sources

About the author
Nextomoro

AI Research Lab Intelligence

nextomoro tracks progress for AI research labs, models, and what's next.

AI Research Lab Intelligence

Great! You’ve successfully signed up.

Welcome back! You've successfully signed in.

You've successfully subscribed to AI Research Lab Intelligence.

Success! Check your email for magic link to sign-in.

Success! Your billing info has been updated.

Your billing was not updated.